<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9"
        xmlns:news="http://www.google.com/schemas/sitemap-news/0.9"
        xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
        xmlns:image="http://www.google.com/schemas/sitemap-image/1.1"
        xsi:schemaLocation="http://www.sitemaps.org/schemas/sitemap/0.9 http://www.sitemaps.org/schemas/sitemap/0.9/sitemap.xsd http://www.google.com/schemas/sitemap-news/0.9 http://www.google.com/schemas/sitemap-news/0.9/sitemap-news.xsd http://www.google.com/schemas/sitemap-image/1.1 https://www.google.com/schemas/sitemap-image/1.1/sitemap-image.xsd">
    <url>
      <loc>https://www.frenchstemtoday.com/article/910524451-heartbot-ai-partners-with-zyxel-networks-to-bring-secure-genai-access-to-smbs-worldwide</loc>
      <news:news>
        <news:publication>
          <news:name>French STEM Today</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-06T00:00:00+00:00</news:publication_date>
        <news:title>Heartbot AI partners with Zyxel Networks to bring secure GenAI access to SMBs worldwide</news:title>
      </news:news>
        <image:image>
          <image:loc>https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24847906-heartbot-ai-partners-with-zyxel-1201x629.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.frenchstemtoday.com/article/910237340-solaris-endovascular-receives-fda-breakthrough-device-designation-for-solaris-de-a-new-drug-eluting-covered-stent</loc>
      <news:news>
        <news:publication>
          <news:name>French STEM Today</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-05T11:00:35+00:00</news:publication_date>
        <news:title>Solaris Endovascular Receives FDA Breakthrough Device Designation for Solaris DE™, a new Drug-Eluting Covered Stent</news:title>
      </news:news>
        <image:image>
          <image:loc>https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24460542-de-stent-with-drug-on-edges-620x397.jpeg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.frenchstemtoday.com/article/910473428-mathew-knowles-the-architect-behind-beyonc-solange-and-destiny-s-child-s-rise-at-wmf-we-make-future-in-italy</loc>
      <news:news>
        <news:publication>
          <news:name>French STEM Today</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-05T09:37:14+00:00</news:publication_date>
        <news:title>Mathew Knowles, the architect behind Beyoncé, Solange, and Destiny’s Child’s rise, at WMF – We Make Future in Italy</news:title>
      </news:news>
        <image:image>
          <image:loc>https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24847670-mathew-knowles-guest-of-honor-a-1200x628.jpeg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.frenchstemtoday.com/article/909630107-maker-faire-rome-the-european-edition-2026-lance-ses-appels-candidatures-internationaux</loc>
      <news:news>
        <news:publication>
          <news:name>French STEM Today</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-05T09:15:00+00:00</news:publication_date>
        <news:title>Maker Faire Rome - The European Edition 2026 lance ses appels à candidatures internationaux</news:title>
      </news:news>
        <image:image>
          <image:loc>https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/23141173-rencontre-entre-technologie-et-1200x628.jpeg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.frenchstemtoday.com/article/910545481-valneva-to-report-first-quarter-2026-consolidated-financial-results-on-may-13-2026</loc>
      <news:news>
        <news:publication>
          <news:name>French STEM Today</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-05T15:45:00+00:00</news:publication_date>
        <news:title>Valneva to Report First Quarter 2026 Consolidated Financial Results on May 13, 2026</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml-eu.globenewswire.com/media/04f398df-96ac-4b7a-8544-2a2ce2495778/small/val-logo-4c-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.frenchstemtoday.com/article/910545482-valneva-publiera-ses-r-sultats-financiers-consolid-s-du-premier-semestre-le-13-mai-2026</loc>
      <news:news>
        <news:publication>
          <news:name>French STEM Today</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-05T15:45:00+00:00</news:publication_date>
        <news:title>Valneva publiera ses résultats financiers consolidés du premier semestre le 13 mai 2026</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml-eu.globenewswire.com/media/04f398df-96ac-4b7a-8544-2a2ce2495778/small/</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.frenchstemtoday.com/article/910439198-abivax-announces-repurchase-of-royalty-certificates-and-pricing-of-45m-38-5m-offering-of-american-depositary-shares</loc>
      <news:news>
        <news:publication>
          <news:name>French STEM Today</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-05T06:00:00+00:00</news:publication_date>
        <news:title>Abivax Announces Repurchase of Royalty Certificates and Pricing of $45M (€38.5M) Offering of American Depositary Shares</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml-eu.globenewswire.com/media/5470cd7e-c1fe-402f-8673-925c82bbd2fb/small/abivax-logo-rgb-png.png</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.frenchstemtoday.com/article/910342560-nanobiotix-announces-protocol-amendment-to-ongoing-global-phase-3-head-and-neck-cancer-study</loc>
      <news:news>
        <news:publication>
          <news:name>French STEM Today</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T21:29:27+00:00</news:publication_date>
        <news:title>Nanobiotix Announces Protocol Amendment to Ongoing Global Phase 3 Head and Neck Cancer Study </news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/36fb7b98-27d7-46cb-b989-fa31626657b8/small/nanobiotix-logo-jpg.jpg</image:loc>
        </image:image>
    </url>
    <url>
      <loc>https://www.frenchstemtoday.com/article/910342587-nanobiotix-annonce-un-amendement-du-protocole-de-l-tude-mondiale-de-phase-3-sur-le-cancer-de-la-t-te-et-du-cou</loc>
      <news:news>
        <news:publication>
          <news:name>French STEM Today</news:name>
          <news:language>en</news:language>
        </news:publication>
        <news:genres>PressRelease</news:genres>
        <news:publication_date>2026-05-04T21:29:27+00:00</news:publication_date>
        <news:title>NANOBIOTIX ANNONCE UN AMENDEMENT DU PROTOCOLE DE L’ÉTUDE MONDIALE DE PHASE 3 SUR LE CANCER DE LA TÊTE ET DU COU</news:title>
      </news:news>
        <image:image>
          <image:loc>https://ml.globenewswire.com/media/36fb7b98-27d7-46cb-b989-fa31626657b8/small/nanobiotix-logo-jpg.jpg</image:loc>
        </image:image>
    </url>
</urlset>
